Related references
Note: Only part of the references are listed.Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study
Eva A. Coenen et al.
BLOOD (2011)
Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia
Irene Homminga et al.
CANCER CELL (2011)
BCL2 Predicts Survival in Germinal Center B-cell-like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab
Javeed Iqbal et al.
CLINICAL CANCER RESEARCH (2011)
Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo et al.
NATURE (2011)
Inactivating mutations of acetyltransferase genes in B-cell lymphoma
Laura Pasqualucci et al.
NATURE (2011)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D. Morin et al.
NATURE (2011)
Initial genome sequencing and analysis of multiple myeloma
Michael A. Chapman et al.
NATURE (2011)
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2011)
Analysis of the coding genome of diffuse large B-cell lymphoma
Laura Pasqualucci et al.
NATURE GENETICS (2011)
The Genetic Landscape of the Childhood Cancer Medulloblastoma
D. Williams Parsons et al.
SCIENCE (2011)
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Nicolas Stransky et al.
SCIENCE (2011)
High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma
B. Glass et al.
ANNALS OF ONCOLOGY (2010)
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
Jonathan W. Friedberg et al.
BLOOD (2010)
The Mammalian Anti-Proliferative BTG/Tob Protein Family
G. Sebastiaan Winkler
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis et al.
NATURE (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome
Sarah B. Ng et al.
NATURE GENETICS (2010)
Mechanisms of Disease: Aggressive Lymphomas.
Georg Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia
Charles G. Mullighan et al.
NATURE GENETICS (2009)
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma
Masumichi Saito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The histone H1 family: specific members, specific functions?
Annalisa Izzo et al.
BIOLOGICAL CHEMISTRY (2008)
Piccolo modulation of Synapsin1a dynamics regulates synaptic vesicle exocytosis
Sergio Leal-Ortiz et al.
JOURNAL OF CELL BIOLOGY (2008)
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas:: a randomised controlled trial (RICOVER-60)
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2008)
Stromal Gene Signatures in Large-B-Cell Lymphomas
G. Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma
Georg Lenz et al.
SCIENCE (2008)
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma
Linfeng Chen et al.
BLOOD (2008)
Diagnosing and exploiting cancer's addiction to blocks in apoptosis
Anthony G. Letai
NATURE REVIEWS CANCER (2008)
Germinal centres: role in B-cell physiology and malignancy
Ulf Klein et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Patterns of somatic mutation in human cancer genomes
Christopher Greenman et al.
NATURE (2007)
Transforming activity of purinergic receptor P2Y, G protein coupled, 8 revealed by retroviral expression screening
Shin-Ichiro Fujiwara et al.
LEUKEMIA & LYMPHOMA (2007)
Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach
JS Abramson et al.
BLOOD (2005)
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response
S Monti et al.
BLOOD (2005)
Disruption of a new X linked gene highly expressed in brain in a family with two mentally retarded males
V Cantagrel et al.
JOURNAL OF MEDICAL GENETICS (2004)
Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity
RT Costello et al.
LEUKEMIA (2003)
Piccolo, a Ca2+ sensor in pancreatic β-cells -: Involvement of cAMP-GEFII•Rim2•Piccolo complex in cAMP-dependent exocytosis
K Fujimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas
L Pasqualucci et al.
NATURE (2001)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Share Paper
